Sandu Pharmaceuticals Ltd. - Research Center
524703 SANDUPHQ Group (X) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
15.60 |
17.43 |
16.61 |
17.66 |
15.26 |
Operating profit |
0.60 |
0.51 |
0.83 |
0.36 |
0.48 |
Interest |
0.01 |
0.02 |
0.01 |
0.02 |
0.02 |
Gross profit |
0.90 |
0.52 |
0.90 |
0.33 |
0.51 |
EPS (Rs) |
0.61 |
0.21 |
0.57 |
0.11 |
0.28 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
0.31 |
0.03 |
0.09 |
- |
0.04 |
Stock adjustment |
-2.24 |
-0.20 |
-0.11 |
4.19 |
-1.19 |
Raw material |
2.84 |
2.42 |
2.62 |
1.98 |
3.17 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
2.47 |
2.53 |
2.55 |
2.52 |
3.07 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
11.92 |
12.17 |
10.73 |
8.61 |
9.73 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.19 |
0.14 |
0.13 |
0.12 |
0.13 |
Taxation |
0.12 |
0.17 |
0.21 |
0.10 |
0.10 |
Net profit / loss |
0.59 |
0.21 |
0.55 |
0.11 |
0.27 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
9.66 |
9.66 |
9.66 |
9.66 |
9.66 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
3.88 |
2.93 |
4.97 |
2.02 |
3.16 |
GPM (%) |
5.68 |
2.98 |
5.38 |
1.89 |
3.34 |
NPM (%) |
3.73 |
1.19 |
3.30 |
0.62 |
1.79 |